Debrisoquine, guanethidine, propranolol and human sleep.
D000328:Adult; D000578:Amidines / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002540:Cerebral Cortex / Q000502:physiology; D003913:Dextroamphetamine / Q000494:pharmacology; D004569:Electroencephalography; D004576:Electromyography; D004585:Electrooculography; D005260:Female; D006145:Guanethidine / Q000494:pharmacology*; D006801:Humans; D007099:Imipramine / Q000494:pharmacology; D007546:Isoquinolines / Q000494:pharmacology*; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009638:Norepinephrine / Q000502:physiology; D010919:Placebos; D011433:Propranolol / Q000494:pharmacology*; D012890:Sleep / Q000187:drug effects*; D012894:Sleep Stages / Q000187:drug effects; D012895:Sleep, REM / Q000187:drug effects; D013997:Time Factors
D000578:Amidines; D000959:Antihypertensive Agents; D007546:Isoquinolines; D008996:Monoamine Oxidase Inhibitors; D010919:Placebos; D011433:Propranolol; D007099:Imipramine; D003913:Dextroamphetamine; D009638:Norepinephrine; D006145:Guanethidine